TrialJournal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer2019

SWOG S1400B (NCT02785913), a Phase II Study of GDC-0032 (Taselisib) for Previously Treated PI3K-Positive Patients with Stage IV Squamous Cell Lung Cancer (Lung-MAP Sub-Study).

Corey J Langer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.